DS
LinkedIn

Daniel Snyder, Ph.D.

Executive Vice President, Advisory Services, Propel Health Medical Affairs

Bridgewater, New Jersey, United States · 1 connection

Propel Health

Not on Unlinked · Imported profile. Is this you? Claim it

About

I’m a scientist, business leader, and strategist with over 20 years of experience in Medical Affairs. My approach to initiatives is data-driven, collaborative, and focused on making an impact in patients’ lives. Working with innovative pharmaceutical, medical device, and biologics companies, I’ve developed successful, business-aligned medical strategies and key opinion leader relationships. Producing insightful publications and offering education based on solid scientific foundations, I enjoy empowering others and advancements in patient care. Some of my achievements include: • Establishing three medical affairs organizations, enhancing scientific engagement and evidence generation. • Earning two Urovant Sciences Excellence Awards for contributions to GEMTESA® launch. • Receiving the Allergan Neuroscience Leadership Award for BOTOX® Chronic Migraine Medical Affairs leadership with this innovative therapeutic solution. I’ve also led eight product launches and supported 21 others, including: • GEMTESA® (Urovant Sciences, 2021): Revolutionary treatment for overactive bladder (OAB). • DYSPORT® Pediatric & Adult formulations (IPSEN Biopharmaceuticals, 2016 & 2015): Key interventions for

Experience

Executive Vice President, Advisory Services, Propel Health Medical AffairsPropel Health
Nov 2025
President3S Solutions, LLC
Apr 2024
Senior Vice President, Head of Medical Affairs, Biopharma and Women's HealthSumitomo Pharma America, Inc.
Jan 2023 to Jan 2024
Senior Vice President, Medical Affairs (Acquired by Sumitomo Pharma America, Inc.)Urovant Sciences
Sep 2022 to Jul 2023
Vice President, Medical AffairsUrovant Sciences
Dec 2019 to Sep 2022
Executive Director, Clinical DevelopmentRevance
Feb 2019 to Dec 2019
Head of Medical Affairs, TherapeuticsRevance
Mar 2018 to Feb 2019
Senior Director, Medical Affairs - Aesthetics and TherapeuticsRevance
Mar 2017 to Mar 2018
Medical Director, Medical Affairs, Neurology / NeuroscienceIpsen
Nov 2014 to Mar 2017
Director of US Medical Affairs, BiotherapeuticsBaxter International Inc.
Jul 2013 to Nov 2014
Senior Medical Scientific Manager, Regional Scientific Services, Medical AffairsAllergan
Jul 2012 to Jun 2013
National Director, Allergan Medical - Regional Scientific Services - Medical AffairsAllergan
Feb 2011 to Jul 2012
Senior Medical Scientific Manager, Regional Scientific Services, Medical AffairsAllergan
Feb 2010 to Jan 2011
Medical Scientific Manager, Regional Scientific Services, Medical AffairsAllergan
Nov 2007 to Feb 2010
Medical Science LiaisonTalecris Biotherapeutics
Jan 2005 to Jan 2008
Vice President R&DColoplast
Jan 2002 to Jan 2005
Director of New Technology DevelopmentQualis Basic company page — company details not listed yet
Jan 2000 to Jan 2002
Principal ScientistMerck
Jan 1993 to Jan 2000

Education

Gustavus Adolphus College
Bachelor's degree Chemistry
University of Iowa
Ph.D. Organometallic Chemistry
Gustavus Adolphus College
B.A. Chemistry